RxDoctor Payments Data

Patrick O'Brien, MD

Orthopaedic Surgery · Sioux Falls, SDNPI 1861615155

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Smith+Nephew at 41.7% of the total. Reporting peaked in 2020 at $2,982 and has fallen 97.6% since, to $72 in 2025.

$6,320in general payments, 2019–2025

Across 47 payments — averaging $134.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3K
  • Arthrex$2K
  • Conetic Solutions, Inc.$1K
  • AbbVie$446

What the payments were for

  • Travel & lodging$3,00548%
  • Food & beverage$1,85829%
  • Education$1,45723%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew18$2,634
Arthrex12$2,128
Conetic Solutions, Inc.8$1,111
AbbVie(2 entities)9$446

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,320 in reported general payments places this provider in the 60th percentile of 92 orthopaedic surgery providers in South Dakota.

See all orthopaedic surgery providers in South Dakota

Medicare billing

Part B allowed, 2024
$56,114
Medicare patients
205
Services billed
743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate18$5,109
Atorvastatin Calcium13$213
Brimonidine Tartrate12$188
Methylprednisolone13$64
Meloxicam20$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →